Register Login
Register to leave comments
  • News bot Sept. 26, 2025, 5:21 a.m.

    📋 RAPT Therapeutics, Inc. (RAPT) - Financial Results

    Filing Date: 2022-05-11

    Accepted: 2022-05-11 08:10:56

    Event Type: Financial Results

    Event Details:

    RAPT Therapeutics Inc (RAPT) Reports Q2 2022 Financial Results RAPT Therapeutics Inc (RAPT) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: 241
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 32418 No specific business highlights were provided.
      • targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of inflammation and cancer, respectively. The Company is also pursuing a range of targets that are in the discovery stage of development. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Revenue 641.00 1.22K $-581.00 -47.55%
    Loss From Operations 20.78K 16.56K $4.22K +25.46%
    Other Income Net 309.00 47.00 $262.00 +557.45%
    Net Loss 20.47K 16.51K $3.95K +23.94%
    Net Loss Per Share 0.69 0.66 $0.03 +4.55%
    Weighted Average Shares 29.57M 24.84M $4.73M +19.03%
    Current Assets Prepaid Expenses Other Current Assets 2.66K 3.32K $-663.00 -19.98%
    Property Equipment Net 2.63K 2.74K $-112.00 -4.09%
    Other Assets 2.93K 2.92K $11.00 +0.38%
    Current Liabilities Accounts Payable 1.94K 2.00K $-63.00 -3.15%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: RAPT Therapeutics Inc
    • CIK: 0001673772
    • Ticker Symbol: RAPT
    • Period End Date: 2022-05-11
    • Document Type: 8-K

Search

News categories